NexImmune, Inc.
NEXI
$0.0001
$0.000.00%
06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | -28.30% | -45.60% | -34.98% | 7.26% | -28.96% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -64.93% | -71.93% | -90.86% | -32.72% | -51.12% |
Operating Income | 64.93% | 71.93% | 90.86% | 32.72% | 51.12% |
Income Before Tax | 69.25% | 67.83% | 68.28% | 33.10% | 52.29% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 69.25% | 67.83% | 68.28% | 33.10% | 52.29% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 69.25% | 67.83% | 68.28% | 33.10% | 52.29% |
EBIT | 64.93% | 71.93% | 90.86% | 32.72% | 51.12% |
EBITDA | 64.69% | 72.36% | 92.06% | 33.33% | 52.07% |
EPS Basic | 76.76% | 73.16% | 68.87% | 37.66% | 58.16% |
Normalized Basic EPS | 84.55% | 72.29% | 91.47% | 37.66% | 58.16% |
EPS Diluted | 76.76% | 73.16% | 68.87% | 37.66% | 58.16% |
Normalized Diluted EPS | 84.55% | 72.29% | 91.47% | 37.66% | 58.16% |
Average Basic Shares Outstanding | 32.34% | 19.88% | 1.89% | 7.32% | 14.01% |
Average Diluted Shares Outstanding | 32.34% | 19.88% | 1.89% | 7.32% | 14.01% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |